Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of JNJ-87890387 for Advanced Solid Tumors

for
Neoplasms, Advanced Solid Tumors
Location: Grand Rapids MI, Nashville TN
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06178614

Phase 1, Recruiting

Role of Gut Microbiome in Cancer Therapy

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT05112614

Recruiting

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Fairfax VA, Grand Rapids MI, Irving TX, Austin TX,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06804824

Phase 1, Recruiting

5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

for
Neoplasms, Solid Tumors
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT03366116

Phase 1, Recruiting

Radiotherapy Patient Education With Virtual Reality

for
Anxiety, Cancer
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06506435

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Personalized Models for Cancer Research

for
Solid Tumor, Adult
Location: New York NY
Sponsor: New York Stem Cell Foundation Research Institute

Sex: All

Age: 18+

Code: NCT06350539

Recruiting

A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors

for
Advanced Cancer, Gastric Cancer, Breast Cancer,
Location: Winston-Salem NC, Birmingham AL, Scottsdale AZ,
Sponsor: Minneamrita Therapeutics LLC

Sex: All

Age: 18+

Code: NCT03129139

Phase 1, Recruiting

IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

for
Cancer
Location: Philadelphia PA
Sponsor: State University of New York at Buffalo

Sex: All

Age: 18+

Code: NCT06206941

Recruiting

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06040541

Phase 1, Recruiting

A Prospective Natural History Study of Lymphatic Anomalies

for
Lymphatic Diseases, Lymphatic Abnormalities
Location: Bethesda MD
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: All

Age: 0 - 70+

Code: NCT05731141

Recruiting

A Registry for People With T-cell Lymphoma

for
T-cell Lymphoma, NK-Cell Lymphoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0+

Code: NCT05978141

Recruiting

Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Huntersville NC
Sponsor: Nanjing Zenshine Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05118841

Phase 1, Recruiting

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

for
Diabetes Mellitus, Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03415139

Recruiting

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation

for
Advanced Solid Tumors
Location: Orange City FL, Lake City FL, Houston TX
Sponsor: Abion Inc

Sex: All

Age: 18+

Code: NCT05541822

Phase 2, Recruiting

Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

for
Symptoms and Signs, Cancer, Childhood Cancer
Location: Richmond VA, Kansas City MO, Salt Lake City UT
Sponsor: Virginia Commonwealth University

Sex: All

Age: 15 - 29

Code: NCT05958316

Recruiting

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

for
Cancer, Thoracic Cancer, Gynecologic Cancer,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06633224

Recruiting

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, Fairfax VA, Plantation FL, Tamarac FL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05785741

Phase 1, Phase 2, Recruiting

A Study of PYX-201 in Advanced Solid Tumors

for
Solid Tumor, Advanced Solid Tumor
Location: Boston MA, Providence RI, New York NY, Philadelphia PA,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT05720117

Phase 1, Recruiting

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor
Location: Denver CO, San Antonio TX, Duarte CA, LA CA,
Sponsor: ABL Bio, Inc.

Sex: All

Age: 18+

Code: NCT04762641

Phase 1, Recruiting

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: New York NY, Fairfax VA, Margate FL, Plantation FL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05914116

Phase 1, Phase 2, Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial